Cuba conducts phase III clinical trial for ataxia type two drug
A phase III clinical trial to evaluate the efficacy and safety of the nasal administration of NeuroEPO in adult patients with spinocerebellar ataxias is being successfully developed in Cuba.
- Written by Redacción ¡ahora!
- Category: Health
- Hits: 1650